Breast Neoplasms: all 12,820 studies
Page 87 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast CancerStatus unknownNCT03024580Phase 2
- The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer PatientsStatus unknownNCT03024463
- Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRIStatus unknownNCT03022864
- Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast CancerCompletedNCT03022162
- Laser Fluorescence in Cancer Surgical TreatmentStatus unknownNCT03021200Not applicable
- Treating Verbal Memory Deficits Following Chemotherapy for Breast CancerCompletedNCT03017560Not applicable
- A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast CancerCompletedNCT03017404Not applicable
- Immunotherapy Vaccine and Herceptin in Breast CancerCompletedNCT03014076Phase 1
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy VolunteersCompletedNCT03013881Phase 1
- A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer PatientsCompletedNCT03013504Phase 3
- Identification of C7; Evaluations of 2 Sonographic Methods Using a Transverse and a Sagittal Scan.CompletedNCT03012893Not applicable
- Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast CancerCompletedNCT03012230Phase 1
- A Comparative Study Between Oncoplastic Breast Surgery and Standard Conservative Surgery:Margin Status and Patient SatisfactionCompletedNCT03012152Not applicable
- Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast CancerStatus unknownNCT03011060Phase 3
- Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.CompletedNCT03010371Not applicable
- Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)TerminatedNCT03008031Not applicable
- Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerCompletedNCT03007992Phase 2
- Improving the Approach to and Management of the Older Metastatic Breast Cancer PatientCompletedNCT03007641Not applicable
- PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03006614Phase 3
- To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast CancerActive, not recruitingNCT03006172Phase 1
- Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer SurgeryWithdrawnNCT03005860Not applicable
- Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast CancerCompletedNCT03003611
- Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the BreastCompletedNCT03002766Phase 2
- Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast CancerStatus unknownNCT03002532Not applicable
- A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast CancerSuspendedNCT03002103Phase 3
- Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI)CompletedNCT03000920Not applicable
- RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast CancerCompletedNCT03000764Not applicable
- HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeStatus unknownNCT03000192
- Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer PatientsCompletedNCT03000036Not applicable
- Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyActive, not recruitingNCT02999074Not applicable
- Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant ExposureCompletedNCT02997995Phase 2
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryCompletedNCT02997553Phase 3
- Feasibility of Breast Cancer Risk Evaluation in Women From the General PopulationStatus unknownNCT02997384
- Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerCompletedNCT02996825Phase 1
- Breast, Omega 3 Free Fatty Acid, Ph 0CompletedNCT02996240Not applicable
- Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled TrialCompletedNCT02996201Not applicable
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
- GEriatric Determinants of Curative RAdiotherapy Scheme Choice for Breast Cancer ELderly Patient Treatment Compliance and ToleranceTerminatedNCT02994914Not applicable
- Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal PositivityCompletedNCT02994225Not applicable
- Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast CancerTerminatedNCT02993094Phase 1/2
- Decongestive Exercise and Compression for Breast Cancer Related Lymphedema ManagementCompletedNCT02992782Not applicable
- Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary UltrasoundStatus unknownNCT02992769
- Predictors of Adjuvant Endocrine Therapy in Women With Breast CancerStatus unknownNCT02992730
- Exercise Effect on Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT02991677Not applicable
- Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast CancerTerminatedNCT02990845Phase 1/2
- A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I SymporterWithdrawnNCT02988648Phase 1/2
- Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast CancerNo longer availableNCT02985658
- Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast CancerCompletedNCT02983279Not applicable
- G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerStatus unknownNCT02983071Phase 1/2
- Effect of Low vs Moderate-intensity Endurance Exercise on Physical Functioning Among Breast Cancer SurvivorsCompletedNCT02982564Not applicable
- The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer SurvivorsStatus unknownNCT02982421Not applicable
- Methylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer PatientsStatus unknownNCT02982148Phase 4
- Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in ChinaStatus unknownNCT02981485Phase 2
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- Assessing Breast Density's Value in Imaging - A Comparative Effectiveness StudyStatus unknownNCT02980848
- Delphinus SoftVue Prospective Case Collection - ARM 2CompletedNCT02977247
- Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound GuidanceTerminatedNCT02975128Not applicable
- A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast CancerStatus unknownNCT02973737Phase 3
- SFX-01 in the Treatment and Evaluation of Metastatic Breast CancerCompletedNCT02970682Phase 2
- A Home-Based Study to Enhance Activity in Breast Cancer SurvivorsCompletedNCT02969291Not applicable
- Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast CancerStatus unknownNCT02967146Phase 3
- Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic CancersStatus unknownNCT02966574Not applicable
- The p53 Breast Cancer TrialActive, not recruitingNCT02965950Phase 2
- Personalized Molecular Profiling in Cancer Treatment at Johns HopkinsActive, not recruitingNCT02965755Not applicable
- The Effect of Acupoint Massotherapy on Relieving Chemotherapy-induced MyelosupressionStatus unknownNCT02964286Not applicable
- Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer SurvivorsCompletedNCT02963740Not applicable
- Adapted Physical Activity for Breast Cancer HER2 Positive PatientTerminatedNCT02963363Not applicable
- Evaluation of Tomosynthesis for Characterization and the Management of Breast LesionsStatus unknownNCT02959398Not applicable
- A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast CancerCompletedNCT02958852Phase 2
- Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal IrradiationActive, not recruitingNCT02958774Not applicable
- Prospective Clinical Investigation Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in MastectomyCompletedNCT02958449Not applicable
- Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast CancerCompletedNCT02958332Not applicable
- The Genetic Education for Men Trial: Web-Based Education vs. Standard CareCompletedNCT02957981Not applicable
- Web-Base App To Improve Aromatase Inhibitor AdherenceCompletedNCT02957526Not applicable
- An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive, not recruitingNCT02955940Phase 2
- Know Your Risk: Assessment at Screening for Breast Cancer - Pilot StudyCompletedNCT02954900Not applicable
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerActive, not recruitingNCT02954874Phase 3
- Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi ArabiaCompletedNCT02954471
- A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
- Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2CompletedNCT02952729Phase 1
- A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsStatus unknownNCT02950064Phase 1
- Effectiveness of Nefopam in Breast Cancer SurgeryStatus unknownNCT02949310Not applicable
- MyHealth: Follow-up After Breast Cancer TreatmentStatus unknownNCT02949167Not applicable
- Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast CancerCompletedNCT02948764Not applicable
- Economic and Social Disparities and Breast CancerCompletedNCT02948478
- TARGeted Intraoperative radioTherapy (TARGIT) Registry DatabaseStatus unknownNCT02947425
- S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
- A Culturally Sensitive Social Support InterventionCompletedNCT02946697Not applicable
- Health Benefits of Expressive Writing Among Chinese Breast Cancer SurvivorsCompletedNCT02946619Not applicable
- Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast CancerWithdrawnNCT02944721Not applicable
- The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive ChemotherapyCompletedNCT02944604Phase 4
- Four Conversations RCTCompletedNCT02944344Not applicable
- The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.Active, not recruitingNCT02942615Not applicable
- Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerActive, not recruitingNCT02942355Phase 2
- Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast CancerCompletedNCT02941536Not applicable
- Weight Loss Pilot Study in Postmenopausal Breast Cancer SurvivorsCompletedNCT02940470Not applicable
- An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast CancerStatus unknownNCT02939274Phase 2
- Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer SurvivorsCompletedNCT02938780Not applicable
- Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy TreatmentTerminatedNCT02936947Not applicable
- A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine TherapyCompletedNCT02935920Not applicable